Characteristic | N = 47 (N, %) |
---|---|
Up-front therapy MPV ± R followed by WBRT + HIDAC MPV ± R followed by HIDAC WBRT isolated Steroids ± intrathecal chemotherapy | 23 (48.9) 17 (36.1) 04 (8.5) 03 (6.5) |
Palliative or curative WBRT | 27 (57.4) |
 ≥ 1 line of therapy | 10 (21.2) |
ASCT consolidation | 0 (0) |
Infection | 13 (27.6) |
Febrile neutropenia | 06 (12.7) |
G3/G4 neutropenia | 08 (17.0) |
G3/G4 thrombocytopenia | 06 (12.7) |
G3/G4 acute kidney injury | 08 (17.0) |
G3/G4 mucositis | 05 (10.6) |
Dementia | 03 (6.3) |